BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30191992)

  • 1. Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.
    Chan CY; Lin TY; Sheu JJ; Wu WC; Huang CY
    J Cell Physiol; 2019 Apr; 234(4):4375-4384. PubMed ID: 30191992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
    Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
    Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1.
    Li K; Zhou Z; Li J; Xiang R
    Technol Cancer Res Treat; 2020; 19():1533033820959404. PubMed ID: 33327874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine (NAC) inhibits cell growth by mediating the EGFR/Akt/HMG box-containing protein 1 (HBP1) signaling pathway in invasive oral cancer.
    Lee MF; Chan CY; Hung HC; Chou IT; Yee AS; Huang CY
    Oral Oncol; 2013 Feb; 49(2):129-35. PubMed ID: 22944050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
    Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
    J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
    Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
    J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
    He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
    Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1.
    Su C; Cheng X; Li Y; Han Y; Song X; Yu D; Cao X; Liu Z
    Cancer Med; 2018 Jun; 7(6):2485-2503. PubMed ID: 29663730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
    Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
    Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
    Lee MF; Hsieh NT; Huang CY; Li CI
    J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
    Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
    J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
    Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
    J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP-13 and JNK pathway.
    Ho HY; Chen MK; Lin CC; Lo YS; Chuang YC; Hsieh MJ
    J Cell Mol Med; 2023 Dec; 27(23):3796-3804. PubMed ID: 37710409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
    Yao J; Luo Y; Zeng C; He H; Zhang X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
    Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
    Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
    Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
    Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of transcription factor HBP1 in anticancer efficacy of EGFR inhibitor erlotinib in HNSCC.
    Chan CY; Chang CM; Chen YH; Sheu JJ; Lin TY; Huang CY
    Head Neck; 2020 Oct; 42(10):2958-2967. PubMed ID: 32677158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.